Titlebook: Clinical Applications of Botulinum Neurotoxin; Keith A. Foster Book 2014 Springer Science+Business Media New York 2014 botox.botulism.dysp

褪色

Clinical Use of Botulinum Neurotoxin: Neuromuscular Disorders,on and relaxation of the muscle with a duration of several months. This initial application has been followed by use of the neurotoxin to treat a wide range of disorders of muscle hyper-contraction. Botulinum neurotoxin is now a major clinical product for the treatment of spasticity and muscle hyper

钉牢

Clinical Use of Botulinum Neurotoxin: Autonomic Conditions,clinical utility in treating conditions involving hyperactivity of the autonomic nervous system, including hyperhidrosis, hypersalivation and conditions of smooth muscle hyperactivity. These clinical uses of the neurotoxin are reviewed in this chapter.

Alpha-Cells

Clinical Use of Botulinum Neurotoxin: Urogenital Disorders Including Overactive Bladder,ine (ACh) release at the presynaptic cholinergic neuromuscular junction and induces a flaccid paralysis. This impact on the bladder has made BoNT-A an attractive therapeutic option for detrusor overactivity (DO) due to neurogenic and idiopathic reasons that are refractory to traditional treatment wi

巨硕

urethritis

流浪者

Interregnum

Grundlagen und Forschungsdesign,ly effective) for postherpetic and posttraumatic neuralgia, pain of plantar fasciitis, piriformis syndrome and pain in total knee arthroplasty. Level C evidence (one class II study—possibly effective) denotes allodynia of diabetic neuropathy, chronic low back pain, painful knee osteoarthritis, anter

打折

Book 20093rd editione zur Verfügung. Um seine Aufgaben ordnungsgemäß erfüllen und seine Handlungsspielräume effektiv nutzen zu können, ist für den Geschäftsführer die Kenntnis der rechtlichen Rahmenbedingungen unerlässlich. Auch ist er daran interessiert, seine haftungsrechtlichen Risiken zu erkennen und zu minimieren.